Wilson Sonsini Goodrich & Rosati advised Forte Biosciences on the deal. Forte Biosciences, a clinical-stage biopharmaceutical company, announced the pricing of an underwritten public offering of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
